Previous close | 500.40 |
Open | 502.60 |
Bid | 501.80 x 10000 |
Ask | 504.60 x 10000 |
Day's range | 502.60 - 502.60 |
52-week range | 370.00 - 506.20 |
Volume | |
Avg. volume | 3 |
Market cap | 118.127B |
Beta (5Y monthly) | 0.83 |
PE ratio (TTM) | 20.29 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 6.08 (1.21%) |
Ex-dividend date | 10 Jun 2024 |
1y target est | N/A |
INDIANAPOLIS, June 26, 2024--Elevance Health (NYSE: ELV) will release second quarter 2024 financial results on July 17, 2024, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:
INDIANAPOLIS, May 30, 2024--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, Florida on June 12 at 1:20 p.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the "Investors" link. You may also access the link here.
INDIANAPOLIS, May 20, 2024--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Bernstein's 40th Annual Strategic Decisions Conference in New York City, on May 31 at 9:00 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the "Investors" link. You may also access the link here.